Steve Worland, Atomwise CEO
February 18, 2025 07:00 AM EST
People
Financing
AI

Ex­clu­sive: Atom­wise, a once high-fly­ing AI start­up, taps biotech vet as CEO to lead pared-down com­pa­ny

Andrew Dunn

Senior Biopharma Correspondent

Atom­wise spent most of its first 12 years talk­ing up the po­ten­tial of AI in mak­ing mol­e­cules. Now, the biotech start­up is turn­ing to an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

FDA's Pe­ter Marks re­signs, say­ing he won't ac­cept Kennedy's 'mis­in­for­ma­tion and lies'

Blue­bird gets new M&A bid, seek­ing to top pri­vate eq­ui­ty of­fer

‘Peo­ple will die’: End of NIH grants guts work be­tween aca­d­e­mics and com­pa­nies to counter next pan­dem­ic

BioN­Tech de­tails promis­ing mid-stage da­ta for its PD-L1xVEGF in ag­gres­sive lung can­cer

FDA ap­proves Sanofi's RNAi drug for he­mo­phil­ia A and B

Lykos’ in­ter­im CEO is set to step down

A service from the Financial Times